全文获取类型
收费全文 | 7665篇 |
免费 | 452篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 217篇 |
妇产科学 | 136篇 |
基础医学 | 1017篇 |
口腔科学 | 74篇 |
临床医学 | 643篇 |
内科学 | 2258篇 |
皮肤病学 | 176篇 |
神经病学 | 834篇 |
特种医学 | 133篇 |
外科学 | 915篇 |
综合类 | 21篇 |
一般理论 | 4篇 |
预防医学 | 614篇 |
眼科学 | 60篇 |
药学 | 350篇 |
中国医学 | 11篇 |
肿瘤学 | 649篇 |
出版年
2023年 | 38篇 |
2022年 | 87篇 |
2021年 | 238篇 |
2020年 | 106篇 |
2019年 | 208篇 |
2018年 | 257篇 |
2017年 | 161篇 |
2016年 | 141篇 |
2015年 | 167篇 |
2014年 | 303篇 |
2013年 | 445篇 |
2012年 | 660篇 |
2011年 | 598篇 |
2010年 | 366篇 |
2009年 | 330篇 |
2008年 | 522篇 |
2007年 | 569篇 |
2006年 | 538篇 |
2005年 | 459篇 |
2004年 | 431篇 |
2003年 | 336篇 |
2002年 | 312篇 |
2001年 | 81篇 |
2000年 | 72篇 |
1999年 | 75篇 |
1998年 | 48篇 |
1997年 | 53篇 |
1996年 | 39篇 |
1995年 | 40篇 |
1994年 | 33篇 |
1993年 | 30篇 |
1992年 | 51篇 |
1991年 | 52篇 |
1990年 | 53篇 |
1989年 | 39篇 |
1988年 | 32篇 |
1987年 | 30篇 |
1986年 | 32篇 |
1985年 | 21篇 |
1984年 | 11篇 |
1983年 | 11篇 |
1982年 | 8篇 |
1981年 | 7篇 |
1980年 | 5篇 |
1979年 | 10篇 |
1978年 | 5篇 |
1975年 | 5篇 |
1974年 | 5篇 |
1973年 | 4篇 |
1972年 | 4篇 |
排序方式: 共有8147条查询结果,搜索用时 819 毫秒
1.
2.
3.
4.
5.
Germ cell tumors of the testes represent a unique paradigm of diseases which can be cured even in extremely advanced phase.
Unfortunately, this makes them unique among adult solid tumors. Seminoma and non seminoma are relatively rare with approximatively
25,000 patients in Europe per year, but numbers are increasing world wide. Different strategies are needed depending on stage
and prognostic scores. Seminoma is extremely sensitive to radiation therapy and chemotherapy, while all germ cell tumors show
a very good response to chemotherapy. Clinical stage I seminoma is currently treated with radiation, single course carboplatin
or surveillance policy. Clinical stage I non seminoma can also be approached with different strategies such as retroperitoneal
lymph node dissection, observation or one-two courses of standard chemotherapy. Stage II seminoma may be treated with either
radiation or chemotherapy, while for all advanced stages chemotherapy is mandatory. Since the mid-eighties PEB (Cisplatin,
Etoposide and Bleomycin) is the regimen of choice and no other schedule has proved superior in terms of efficacy. Surgery
on the residual disease is crucial to the whole strategy and should be performed or attempted in all cases. Consequently,
the correct treatment strategy for these tumors does not depend only on the ability of a single physician, but on a skilled
team specialized in this particular tumor. Second line therapies (VeIP, PEI, TIP) can cure 25%–40% of patients, but improved
strategies for resistant tumors are desperately needed. High-dose chemotherapy has shown very good results in some studies
while being less impressive in others. In any case, it should remain an option for relapsing patients and could be used in
some cases of upfront chemotherapy in patients with slow marker decline, but this should only be considered in referring centers. 相似文献
6.
7.
8.
C Casanova C G Cote J M Marin J P de Torres A Aguirre-Jaime R Mendez L Dordelly B R Celli 《The European respiratory journal》2007,29(3):535-540
The 6-min walking distance (6MWD) test is used in clinical practice and research into patients with chronic obstructive pulmonary disease (COPD). However, little is known about natural long-term change in this parameter. The 6MWD was measured at baseline and then annually for 5 yrs in 294 patients with COPD and its annual rate of decline was determined. Forced expiratory volume in one second (FEV1) was also measured and the relationship between changes in both markers was explored. At baseline, the median 6MWD was 380 m (range 160-600 m). It declined by 19% (16 m.yr(-1)) over the 5 yrs compared with baseline in patients with American Thoracic Society/European Respiratory Society stage III COPD (FEV1 30-50% predicted) and by 26% (15 m.yr(-1)) in patients with stage IV COPD (FEV1 <30% pred). Over the 5-yr follow-up, the proportion of patients with a minimal clinically significant decline of 54 m increased with the severity of the disease. It was 24% in stage II, 45% in stage III, and 63% in stage IV disease. In contrast, the rate of decline of FEV1 was greater in patients with milder airflow obstruction and lesser in patients with lower absolute FEV1 values. In conclusion, the 6-min walking distance test provides increasingly useful information as the severity of chronic obstructive pulmonary disease increases. 相似文献
9.
Borras Merce; Valdivielso Jose M.; Egido Ramon; Vicente de Vera Pilar; Bordalba Josep Ramon; Fernandez Elvira 《Nephrology, dialysis, transplantation》2006,21(3):789-791
10.